Institut AllergoSan Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2018
NCT04471116
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Allergosan | Institut AllergoSan | Institute AllergoSan